Fig. 4From: Effectiveness and safety of biological and target synthetic drugs treatment for psoriatic arthritis: a systematic review with network meta-analysisFunnel plot of primary outcomes analyzed in network meta-analysis at 6-month follow-up. a - ACR 50; b - PsARC; c - Serious adverse events. Abbreviations: ADA adalimumab, ETA etanercept, GOL golimumab, IFN infliximab, SEC secukinumab, PBO placebo, TOF tofacitinibBack to article page